Welltrients for Life, Inc. Where Wellness & Nutrients come Together. Do not be Brain Dead be Be Welltrient Smart
  Wellness Advantage ™
LoginID:
Password
Tuesday, October 6th, 2026   We believe in Two great powers: the power of Nature and the power within one´s self.
Home   Food Science   Health Sciences   Mind & Body Concepts   Sick Care Systems (Health Care Systems)   Plant Sciences   Alchemy Center   Back  
Infectious Associated Disease |11067|
Infectious Associated Disease Subsets
Viral IADs
Myocardial Infarction
Cancers & IADs
Chronic Fatigue Syndrome
Depression (clinical)
Pathogenic Obesity
See Also ↔
 
 
“Infectious Associated Diseases (IAD)”  

Infectious Associated Disease

  In our body, an Infectious Associated Disease (IAD) is any dis-ease linked associated or correlated with at least one infectious pathogen. *
[11193]
“Cancers & IADs”  

Cancers and Infectious Associated Diseases (IADs)

  In our body, Cancers are an Infectious Associated Disease (IAD) linked or correlated with at least one infectious pathogens. *
[77160]
“Tumors (Neoplasms)”  

Tumor

  In our body, a Tumor is a solid or fluid-filled (cystic) lesion that has the appearance of being enlarged.

Tumors and Infectious Associated Diseases (IADs)

  In our body, Tumors (Neoplasms) are an Infectious Associated Disease (IAD) process linked or correlated with at least one infectious pathogen.

Neoplasms & Tumors

  In our body, Neoplasms and Tumor are abnormal masses of tissue, with a tumor being a formed mass of neoplasm (pre-tumor), although some neoplasms are unformed.

In our body, different body tissue types give rise to different Tumors (Neoplasms), both benign and malignant. The following tables show the different kinds of tumors each of the following tissue types are vulnerable to:

*
[11046]
“Alzheimer Disease (Alzheimer's disease)”  

Alzheimer's Disease

  In our body's brain, Alzheimer's Disease, the most common form of dementia among older people, is a chronic progressive neurodegenerative dis-order, characterized in the brain by amyloid plaque deposits and neurofibrillary tangles.
  In our body's brain, Alzheimer's Disease, is an infectious associated dis-ease linked or correlated with more then one infectious pathogen.

In our body, Alzheimer's Disease is associated with the bacteria Chlamydia pneumoniae and Helicobacter pylori. Herpes simplex virus 1 is associated with Alzheimer's disease in individuals that possess the APOE4 form of the APOE Gene (APOE4 may enable the herpes virus to enter the brain).
  Examples of Alzheimer's disease & related dis-orders include:
  • Early Onset Alzheimer Disease
  • Late Onset Alzheimer Disease
  • Focal Onset Alzheimer's Disease
  • Familial Alzheimer Disease (FAD)
  • Presenile Dementia
  • Acute Confusional Senile Dementia
Alzheimer disease is a genetically heterogeneous disorder that may include:
  • Alzheimer disease-1 (AD1)
  • Alzheimer disease-2 (AD2)
  • Alzheimer disease-3 (AD3)
  • Alzheimer disease-4 (AD4)
  • Alzheimer disease-5 (AD5)
*
[12797]
“Amyotrophic Lateral Sclerosis (ALS)”  

ALS (Amyotrophic Lateral Sclerosis)

  In our body, the neurodegenerative dis-ease, Amyotrophic Lateral Sclerosis (ALS), aka Lou Gehrig's Disease, is a form of a motor neuron dis-ease and a degenerative motor neuron dis-order, affecting upper motor neurons (effector neurons) in the brain and lower motor neurons in the brain stem and spinal cord (spinal cord dis-eases).
  In our body, the infectious associated dis-ease, Amyotrophic Lateral Sclerosis (ALS) is indicative to a specific set of signs, symptoms or other health indicators, associated with a health challenge linked or correlated with TDP-43 proteinopathies and at least one infectious pathogen the echovirus (enteric cytopathic human orphan viruses) causing an echovirus infection of the central nervous system, and with retrovirus activity.

Forms of ALS

  There are many different types of amyotrophic lateral sclerosis (ALS) distinguished by the signs, symptoms and the genetic cause or lack of genetic association.
  • Sporadic - the most common form of ALS in the United States
  • familial ALS (familial amyotrophic lateral sclerosis) - occurring more than once in a family lineage (genetic dominant inheritance) accounts for a very small number of cases in the United States
  • Guamanian - an extremely high incidence of ALS was observed in Guam and the Trust Territories of the Pacific
**
[15504]
“Anorexia Nervosa”  
  In our body, Anorexia Nervosa is the allopathic name of an eating dis-order, characterized by the lack or loss of appetite, called anorexia, indicative to a specific set of signs, symptoms or other health indicators, associated with an anorexic health challenge.
  In our body, Anorexia Nervosa is an infectious associated dis-ease linked or correlated with at least one infectious pathogen **
[16513]
“Anxiety Disorders”  
  In our body, Anxiety Disorders are mental dis-orders of anxieties defined by symptoms that may manifest into a physical conditions.

Identical physical conditions (symptoms) to those of an anxiety dis-order (anxiety attack), may be caused by an overactive thyroid gland or some other physiological activities or by the use of caffeine (or drugs like, corticosteroids or amphetamines).
  In our body, an Anxiety Disorder is a persistent and disabling anxiety.
  In our body, an anxiety disorder is an infectious associated disease linked or correlated with at least one infectious pathogen namely the Cytomegalovirus.
Examples of some anxiety dis-orders may include:

  • Catastrophization
  • Dental Anxiety
  • Castration Anxiety

**
[13320]
“Asthma (Bronchial Asthma)”  

Asthma

  In our body, as an obstructive lung dis-ease, Asthma (Bronchial Asthma) is a series of complex, overlapping individual chronic inflammatory airway dis-eases or phenotypes, each defined by its unique interaction between genetic and environmental factors, characterized by episodic reversible airway obstruction that variably presents with cough, wheezing, shortness of breath (dyspnea), or chest tightness.

In our body, the bronchial dis-order, Asthma (Bronchial Asthma) may clinically be defined by abnormal, reversible bronchoconstriction in response to a variety of non-specific stimuli with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction, characterized by wheezing (a respiratory sound), spasmodic contraction of airway smooth muscle and paroxysmal dyspnea (dyspnea).

In our body, the bronchial dis-order, Asthma (Bronchial Asthma) may be an infectious associated dis-ease linked or correlated with at least one infectious pathogen.
  Examples of asthma (bronchial asthma) subsets, conditions, subjects, concepts, processes and related entities include:
  • Induced Asthma
    • Exercise-Induced Asthma
    • Exercise-induced bronchoconstrictions
    • Occupational Asthma
    • Aspirin-Induced Asthma
  • Asthma Genetic Predisposition
  • Allergic asthma
  • Non-allergic asthma
  • Cough-variant asthma
  • Nocturnal asthma
  • Status Asthmaticus
  • mild intermittent asthma
  • mild persistent asthma
  • moderate persistent asthma
  • severe persistent asthma
**
[11549]
“Atherosclerosis”  
  In our body's arteries, Atherosclerosis is an abnormal thickening and loss of elasticity of the arterial walls, occuring with the formation of atherosclerotic plaques in the arterial intima (a tunica intima).


  In our body's arteries, Atherosclerosis is primarily a dis-ease of the innermost layer of arterial wall, the intima, which comprises smooth muscle cells lined by a monolayer of endothelial cells.

Into our body, Atherosclerosis is an infectious associated dis-ease linked or correlated with at least one infectious pathogen.
  The proliferation of vascular smooth muscle cells (SMC) and impaired nitric oxide (NO) production are both crucial pathophysiological processes in the initiation and development of atherosclerosis. **

[12330]
“Attention Deficit Disorder with Hyperactivity (ADHD)”  

Attention Deficit Hyperactivity Disorder

  In our body, the dis-ease, Attention Deficit Hyperactivity Disorder (ADHD) is the allopathic name, indicative to a specific set of signs, symptoms or other health indicators, associated with a health challenge.

Attention Deficit Hyperactivity Disorder (ADHD)

  In our body, Attention Deficit Hyperactivity Disorder (ADHD) is a behavior disorder, in which features signs of developmentally inappropriate inattention, impulsivity, and hyperactivity.


  In our body, Attention Deficit Hyperactivity Disorder (ADHD) is an infectious associated disease linked or correlated with at least one infectious pathogen. **

[13101]
“Autistic Disorders (Autism)”  

Autism

  In our body, the dis-ease, Autistic Disorder (Autism) is the allopathic name, indicative to a specific set of signs, symptoms or other health indicators, associated with a health challenge.


  In or from our body, Autistic Disorder (Autism) is a pervasive development dis-orders, often beginning in childhood, marked by the presence of abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest.
  In our body, autism is an infectious associated dis-ease linked or correlated with at least one infectious pathogen and one toxic mineral. **

[13450]
“Autoimmune Diseases (Autoimmune Disorders)”  

Autoimmune Disorders

  In our body, Autoimmune Diseases, are immune system dis-eases, characterized by the production of antibodies (autoantibodies), that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
  In our body, the group described as Autoimmune Diseases are often associated as an infectious associated disease that is linked or correlated with at least one infectious pathogen.
  Examples of autoimmune dis-eases include:
  • Lambert-Eaton Myasthenic Syndrome
**
[11122]
“Bipolar Disorder (Manic Depression) ”  

Bipolar Disorder

  In our body, the brain dis-order, Bipolar Disorder is a common affective neuropsychiatric dis-order marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrences, indicative to a specific set of signs, symptoms or other health indicators, associated with mental health challenges.
  In our body, bipolar disorder is a serious mental illness characterized by recurrent episodes of major depression and periods of mania or hypomania, with 3 times as many days depressed than either hypomanic or manic, and may be an infectious associated dis-ease linked or correlated with at least one infectious pathogen. **
[11723]
“Irritable Bowel Syndrome (IBS)”  

Irritable Bowel Syndrome

  In our body's gastrointestinal system, Irritable Bowel Syndrome (IBS) is a symptom-based functional bowel dis-orders, that lacks a clearcut etiology which cannot be allopathically explained by currently definable structural or biochemical causes. IBS has also been called spastic colon or spastic bowel.
  In our body, the funtional dis-order, Irritable Bowel Syndrome (IBS) is a health challenge associated with chronic or recurrent colonic symptoms, characterized by chronic or recurrent abdominal pain, bloating, mucus in feces, and an erratic disturbance of defecation.


  In our body, a Irritable Bowel Syndrome (IBS) is an infectious associated disease linked or correlated with at least one infectious pathogen. **

[14578]
“Diabetes Mellitus”  
  In our body, the endocrine system dis-ease, Diabetes (Diabetes mellitus), the most common metabolic disease resulting from insufficient insulin action (either absolute or relative), is a group of glucose metabolism dis-orders, in which our body has high blood sugar, either because the body does not produce enough insulin, or because cells do not respond to the produced insulins.
  In our body, the glucose metabolism dis-order, Diabetes (Diabetes mellitus) is a heterogeneous group of dis-orders characterized by various degree of chronic hyperglycemia, glucose intolerance and hypoglycemia, associated with numerous subsequent diabetic complications (diabetes complications), and may be accompanied by specific microvascular complications including nephropathy, retinopathy and neuropathy, while increasing the risk of macrovascular complications (coronary heart disease, stroke and peripheral vascular disease).
  In our body, the high blood sugar associated with hyperglycemia from Diabetes (Diabetes mellitus) produces the symptoms of polyuria (frequent urination), polydipsia (increased thirst) and polyphagia (increased hunger). **
[11900]
“Epilepsies (Epilepsy)”  

Epilepsy

  In our body, the multifaceted group of dis-orders, Epilepsy is a disorder of the brain, characterized by an enduring predisposition to generate epileptic seizures, that may be divided into two broad categories partial and generalized, based on the seizure onset zone, both associated with a group of epileptic health challenges characterized by seizures.
  In our body, Epilepsy is is a chronic neurological disorder (neuro condition), characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge.

Epilepsy is an infectious associated dis-ease linked or correlated with at least one infectious pathogen.
  Examples of epilepsy dis-order (seizure dis-order) & related dis-orders include: **
[11240]
“Guillain-Barre Syndrome”  
  In our body, the peripheral nervous system condition, Guillain-Barre syndrome is an acute inflammatory demyelinating polyneuropathy (AIDP), an autoimmune dis-order that affects the nerves of the peripheral nervous system, caused by T cell- mediated cellular immune response directed towards the peripheral myelin.
  In our body, Guillain-Barre Syndrome (GBS) is an infectious associated dis-ease linked or correlated with at least one infectious pathogen.

**

[18730]
“Crohn's Disease of the Intestines”  

Crohn's Disease

  In our body's intestinal system, Crohn's Disease of the Intestines principal behaviors are inflammatory, stricturing, and fistulizing involve any part of the digestive tract from the duodenum through to the anus, with inflammation, extending through the intestinal wall (intestinal mucosa) from the mucosa to the serosa (serous membrane), first described by Crohn, Ginzburg and Oppenheimer in 1932.
  In our body's intestinal system, the gastroenteritis dis-ease, Crohn's Disease is one of the major forms inflammatory bowel dis-ease, indicative to a specific set of signs, symptoms or other health indicators, associated with a chronic transmural inflammation health challenge.
  In our body, Crohn's Disease is an infectious associated disease linked or correlated with at least one infectious pathogen and an imbalance to the intestinal microbiota. **
[13534]
“Acute Myocardial Infarction (Heart Attack)”  

Myocardial Infarction (Heart Attack)

  In our body's heart, an Acute Myocardial Infarction (Heart Attack) is the result from an interruption of blood supply to a part of the heart.

Acute Myocardial Infarction (Heart Attack)

  In our body's heart, an Acute Myocardial Infarction (Heart Attack) is an infectious associated disease linked or correlated with at least one infectious pathogen. **
[19897]
“Tourette Syndrome (Tourette's Disorder)”  

Tourette Syndrome

  In our body, the neuropsychological dis-order, Tourette Syndrome (Tourette's Disorder), aka Gilles De La Tourette's Syndrome, is a complex tic disorder, associated with multiple tics, involving both motor and phonic tics, related to alterations in dopamine metabolism and neurotransmission involving frontal-subcortical neuronal circuits.
  In our body, Tourette Syndrome (Tourette's Disorder) is a heredodegenerative dis-order, indicative to a specific set of signs, symptoms or other health indicators, associated with a movement disorder health challenge.


  In our body, a Tourette Syndrome is an infectious associated disease linked or correlated with at least one infectious pathogen. **

[17605]
“Metabolic Syndrome (Metabolic Syndrome X)”  

Metabolic Syndrome X

  In our body, the metabolic dis-order, Metabolic Syndrome X is a cluster of metabolic risk factors indicative to a specific set of signs, symptoms or other health indicators, associated with the glucose metabolism dis-order insulin resistance.
  In our body, a Metabolic Syndrome X is a dietary mineral deficiency associated dis-ease, and an infectious associated dis-ease linked or correlated with at least one infectious pathogen. **
[15313]
“Systemic Lupus Erythematosus (Lupus Erythematosus)”  

Lupus Erythematosus

  In our body, the autoimmune and multi-system dis-ease, Systemic Lupus Erythematosus (Lupus Erythematosus) is an overlap syndrome indicative to a specific set of signs, symptoms or other health indicators, associated with a various spectrum of clinical and immune abnormalities.
  In our body, a Lupus Erythematosus is an infectious associated disease linked or correlated with at least one infectious pathogen.
  In our body, the immune system dis-ease, Systemic Lupus Erythematosus is autoimmune connective tissue dis-ease indicative to a specific set of signs, symptoms or other health indicators, associated with a health challenge that may involve the BANK1 gene. **
[14971]
“Rheumatoid Arthritis (RA)”  

Rheumatoid Arthritis

  In our body, the immune system dis-order, Rheumatoid Arthritis (RA) is a chronic, systemic inflammatory arthritic infectious associated rheumatological dis-order, linked or correlated with at least one infectious pathogen, that may affect many tissues and organs, but principally attacks synovial joints, and implicated with mechanisms of a autoimmune dis-order.
  In our body, Rheumatoid Arthritis is marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures.
  Examples of some rheumatoid arthritis related conditions include: **
[14282]
“Chronic Obstructive Pulmonary Disease (COPD)”  

Chronic Obstructive Pulmonary Disease

  In our body's lungs, Chronic Obstructive Pulmonary Disease (COPD) is a type of obstructive lung dis-ease
  In our body, Chronic Obstructive Pulmonary Disease (COPD) is an infectious associated disease linked or correlated with at least one infectious pathogen.
  In our body, Chronic Obstructive Pulmonary Disease (COPD) is an infectious associated disease linked or correlated with at least one infectious pathogen. **
[13613]
“Multiple Sclerosis”  
  In our body's central nervous system (CNS), the chronic degenerative dis-ease, Multiple Sclerosis is a physically devastating demyelinating disease of the CNS (brain and spinal cord), characterized by inflammation, demyelination, gliosis and axonal damage in the CNS, associated with axon degeneration, expressed in a complex genetic and immunological milieu.

  In our body's central nervous system (CNS), the chronic inflammatory autoimmune demyelinating disease (demyelinating dis-order), Multiple Sclerosis is indicative to a specific set of signs, clinical symptoms or other health indicators, associated with symptoms including motor disabilities, cognitive deficits and fatigue, as indicated by axonal and neuronal injuries present both in the white and grey matter areas.
  In our body, a Multiple Sclerosis is an infectious associated disease linked or correlated with at least one infectious pathogen. **
[11609]
“Diabetes Mellitus Type 1”  
  In our body, the endocrine system dis-ease, Diabetes Mellitus Type 1 is a type of diabetes, characterized by insulin deficiency.

Diabetes Mellitus Type I

  In our body, a Diabetes Mellitus Type 1 is an infectious associated disease linked or correlated with at least one infectious pathogen. **
[12971]
“Dementia”  
  In our body, the dis-ease, Dementia is the allopathic name, indicative to a specific set of signs, symptoms or other health indicators, associated with an acquired organic cognitive health challenge.
  In our body, Dementia is a multifaceted dysfunction with loss of intellectual abilities involving memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions, that interferes with social or occupational function.

In our body, Dementia is an intellectual decline is usually progressive, and initially spares the level of consciousness and is an infectious associated dis-ease linked or correlated with at least one infectious pathogen. **

[11942]
“Brain Neoplasms (Brain Tumors)”  

Brain Neoplasms

  In our body's brain, Brain Tumor (Brain Neoplasm) is a central nervous system neoplasm of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum.
  In our body, Brain Tumor (Brain Neoplasm) is an infectious associated disease linked or correlated with at least one infectious pathogen, and indicative to a specific set of signs, symptoms or other health indicators, associated with a health challenge.
  Examples of related brain neoplasms and dis-orders include:
In our body, brain tumors may be graded based on how aggressive the tumor cells appear under a microscope, featuring four distinct grades:
  • Grade I brain cancer, tumors grow slowly, rarely spreading into nearby tissues
  • Grade II brain cancer, tumors grow slowly, but may spread into nearby tissue or recur
  • Grade III brain cancer, the tumors grow quickly, likely to spread into nearby tissues with the tumor cells not looking like normal cells
  • Grade IV brain cancer, the tumors grow very quickly and spread very quickly, with the tumor cells not looking like normal cells
**
[11842]
“Chronic Fatigue Syndrome (Chronic Fatigue Immune Dysfunction Syndrome)”  

Chronic Fatigue Syndrome

  In our body, the syndrome, Chronic Fatigue syndrome (CFS), aka Chronic Fatigue Immune Dysfunction Syndrome and Myalgic Encephalomyelitis, is the allopathic name, indicative to a specific set of signs, symptoms or other health indicators, of a dis-order, characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment.
  In our body, Chronic Fatigue syndrome (CFS) is an infectious associated disease linked or correlated with at least one infectious pathogen. **
[12418]
“Vasculitides (Vasculitis)”  

Vasculitis

  In our body, the vascular dis-eases, af Vasculitides are inflammations of any one of the blood vessels which may affect either arteries (as arteritis) or veins (as phlebitis) or both.
  In our body, the vascular dis-order, Vasculitis is an angiitis indicative to a specific set of signs, symptoms or other health indicators, associated with a health challenge.

In our body, a Vasculitis is an infectious associated disease linked or correlated with at least one infectious pathogen.


  Examples of vasculitis include:

  • arteritis
  • aortitis
  • malignant atrophic papulosis
  • Mucocutaneous Lymph Node Syndrome
  • phlebitis
  • Purpura, Schoenlein-Henoch
  • Retinal Vasculitis
  • Shwartzman Phenomenon
  • Systemic Vasculitis
  • Thromboangiitis Obliterans
  • Vasculitis, Central Nervous System
  • Vasculitis, Leukocytoclastic, Cutaneous

**

[12426]
“Carcinoid Tumors”  
  In our body, Carcinoid Tumors is usually small a slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface, that may occur in the gastrointestinal tract (also appendix, lungs and elsewhere).
  In our body, a Carcinoid Tumors is a slow growing neuroendocrine tumor (adenocarcinoid tumor) originating in the cells of the neuroendocrine system.
In our body, Carcinoid Tumors are an infectious associated disease linked or correlated with at least one infectious pathogens and are of neuroendocrine origin derived from a primitive stem cell. **
[12495]
“Coronary Disease (Coronary Heart Disease)”  

Coronary Heart Disease

  In our body's heart, Coronary Heart Disease (Coronary Disease), a form of myocardial ischemia, is any imbalance between myocardial functional requirements and the capacity of the coronary blood vessels to supply sufficient blood flow.
  In our body, the dis-ease, Coronary Heart Disease (Coronary Disease) is the allopathic name, indicative to a specific set of signs, symptoms or other health indicators, associated with a health challenge.

In our body, a Coronary Heart Disease is an infectious associated disease linked or correlated with at least one infectious pathogen.
  Examples of coronary diseases include: **
[12693]
“Depressions (Clinical Depression)”  

Depression

  In our body, the dis-order, Depression (Clinical Depression) is a mental state characterized by a pessimistic sense of inadequacy, a despondent lack of activity and corresponding withdrawal of social interactions. Depression affects a person's mood changes, physical functions and social interactions.

Depressive Behavior

  In our body, the dis-order, Depression (Clinical Depression) is, the allopathic name, indicative to a specific set of signs, symptoms or other health indicators, associated with a health challenge characterized by depressive behavior.
  In our body, a Depression (Clinical Depression) is an infectious associated disease linked or correlated with at least one infectious pathogen. **
[12935]
“Adrenal Gland Neoplasms (Adrenal preTumors)”  
[13305]
“Pathogenic Obesity”  

Obesity and Pathogens

  In our body, Obesity (Pathogenic Obesity) may be an infectious associated disease linked or correlated with at least one infectious pathogens. **
[19534]
“Psoriasis”  
  In our body, Psoriasis is a common, chronic, inflammatory papulosquamous skin dis-ease characterized by rounded erythematous, dry, scaling patches, as a systemic dis-ease centered on inflammation and involvement of cytokines of the Type 1 helper T cell (Th1) pathways.
  In our body, the dis-ease, Psoriasis is an infectious associated disease characterized by epidermal hyperproliferation and infiltration of multiple leukocyte populations, linked or correlated with at least one infectious pathogen (Malassezia furfur).
  Examples of related types of psoriasis are: **
[13630]
“Panic Disorders”  

Panic Disorder

  In our body, the dis-order, Panic Disorder is the allopathic name, indicative to a specific set of signs, symptoms or other health indicators, associated with a health challenge.
  In our body, a panic disorder is an infectious associated disease linked or correlated with at least one infectious pathogen.
  Examples of subsets, concepts, subjects and related entities of panic disorders include:
  • chemically induced panic attacks
  • type I: a single panic attack is the only symptom,
  • type II: only panic attacks occur frequently without any accompanying neurotic or depressive symptoms,
  • type III: a recurrence of panic attacks and the gradual development of neurotic symptoms, such as anticipatory anxiety, generalized anxiety, agoraphobia, or hypochondriasis,
  • type IV: depressive symptoms develop in the course of recurring panic attacks.
    • Type IV-1: depressive symptoms develop secondary to panic attacks and major depression later coexists with panic disorder.
    • Type IV-2: panic disorder continuously changed into major depression.
    • Type IV-3: panic attacks and depressive symptoms are seen independently.
**
[16115]
“Parkinsonian Disorders (Parkinsonism)”  

Parkinsonism (Parkinsonism)

  In our body, the movement dis-orders, Parkinsonian Disorders (Parkinsonism) are a group of neurodegenerative dis-orders which feature extrapyramidal motor function abnormalities characterized by bradykinesia, muscle rigidity, tremor and postural instability.

In our body, the dis-ease, Parkinsonian Disorders (Parkinsonism) is the allopathic name, indicative to a specific set of signs, symptoms or other health indicators, associated with a dis-ease affecting the substantia nigra, a component of the basal ganglia.
  In our body, the Parkinsonian Disorders (Parkinsonism) are a group of movement dis-orders which include Parkinson's Dis-ease and cortical lewy body dis-ease.

In our body, a Parkinsonian Disorders (Parkinsonisms) are infectious associated diseases linked or correlated with at least one infectious pathogen.
  Examples of parkinsonian dis-orders include:

**
[12194]
“Strokes”  

Stroke

  In our body, a Strokes are a group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to brain ischemia or intracranial hemorrhages, generally classified by the type of tissue necrosis, such as the anatomic location, vasculature involved, etiology, age, and if it be hemorrhagic verses non-hemorrhagic.
  In our body, a typical Stroke as a result of blood flow being blocked from part of the brain, deprives the brain of blood and oxygen, resulting in the cell death.

In our body, a Stroke is an infectious associated disease linked or correlated with at least one infectious pathogens.
  Examples of strokes include:
  • Brain Infarction
    • Brain Stem Infarctions
      • Lateral Medullary Syndrome
    • Cerebral Infarction
      • Multi-Infarct Dementia
      • Anterior Cerebral Artery Infarction
      • Middle Cerebral Artery Infarction
      • Posterior Cerebral Artery Infarction
  • Lacunar Stroke
**
[11160]
“Sarcoidosis”  
  In our body, the lymphoproliferative dis-order, Sarcoidosis is a non-caseating granulomatous multi-system dis-ease, that primarily affects the lung and lymphatic systems, characterized by the presence of widespread, non-caseating granulomas, indicative to a specific set of signs, symptoms or other health indicators, associated with an unknown etiology.
  In our body, a Sarcoidosis may be an is a non-infectious granulomatous process or an infectious associated dis-ease which has been linked or correlated with at least one infectious pathogen. **
[16962]
“Schizophrenia (Schizophrenic Disorders)”  

Schizophrenia

  In our body, the highly genetic dis-order, Schizophrenia is a severe emotional disorder of psychotic depth, characteristically marked by a retreat from reality with delusion formation, hallucinations, emotional disharmony, and regressive behavior, indicative to a specific set of signs, symptoms or other health indicators, associated with abnormalities of brain structure and function.
  In our body, a Schizophrenia, associated with ventricular enlargement and a generalized loss of brain tissue, as an infectious associated dis-ease has been linked or correlated with at least one infectious pathogen.
  Examples of schizophrenic disorders include: More examples include: **
[12005]
“Thromboangiitis Obliterans”  
  In our body, the vascular dis-ease, Thromboangiitis Obliterans is an angiitis of an infectious associated dis-ease linked or correlated with at least one infectious pathogen. **
[15387]
“Achilles Tendon (Calcaneal Tendon)”  

Achilles Tendon

  In our body's posterior lower leg, the Achilles Tendon (Calcaneal Tendon) is the largest and strongest tendon of the body, serving in the back of the leg to attach the calf muscles (plantaris muscle, gastrocnemius muscle and soleus muscle (calf muscle)) to the calcaneus (heel bone).
  In our body, the Achilles Tendon (Calcaneal Tendon), as a tough band of fibrous tissue, pulls on the heel when the calf muscles flexes allowing movement so we can stand on our toes when walking, running, or jumping.
  In our body, the Achilles Tendon (Calcaneal Tendon), connects and is cushioned at the heel by two small bursae (small fluid filled sacs), the retrocalcaneal bursa and the subcutaneous calcaneal bursa located on the heel bone. **
[7696]
References & Citations:
1. Wiegerinck JI. et al "Eponyms of the Kager triangle"   J Bone Joint Surg Am. 2012 May 16;94(10):e67  
2. Stoler A. et al "Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation"   Proc. Natl. Acad. Sci. U.S.A. 1985 Jan;82(2)570-574  
3. Blair RD. "Temporal lobe epilepsy semiology"   Epilepsy Res Treat. 2012;2012:751510  
4. Bashiri FA. "Childhood epilepsies: What should a pediatrician know?"   Neurosciences (Riyadh). 2017 Jan;22(1):14-19  
5. Zedan MM. et al "Clinical asthma phenotyping: A trial for bridging gaps in asthma management"   World J Clin Pediatr. 2015 May 8;4(2):13-8  
6. Holcomb IN. et al "FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family"   EMBO J. 2000 Aug 1;19(15):4046-55  
7. Sarkar M. et al "Mechanisms of hypoxemia"   Lung India. 2017 Jan-Feb;34(1):47-60  
8. Oguma T. et al "Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma"   Allergol Int. 2008 Dec;57(4):307-12  
9. Laitinen T. et al "Characterization of a common susceptibility locus for asthma-related traits"   Science 2004 Apr;304(5668)300-304  
10. Kianmehra M. et al "Possible therapeutic effects of Crocus sativus stigma and its petal flavonoid, kaempferol, on respiratory disorders"   Pharm Biol 2020; 58(1): 1140–1149  
11. Paris D. et al "Amelioration of experimental autoimmune encephalomyelitis by anatabine"   PLoS One. 2013;8(1):e55392  
12. Nazari F. et al "Comparing the effects of reflexology and relaxation on fatigue in women with multiple sclerosis"   Iran J Nurs Midwifery Res. 2015 Mar-Apr;20(2):200-4  
13. Ford C. et al "Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate"   Mult Scler. 2010 Mar;16(3):342-50  
14. Solari A. et al "Aminopyridines for symptomatic treatment in multiple sclerosis"   Cochrane Database Syst Rev. 2001;(4):CD001330  
15. Skripuletz T. et al "Pivotal role of choline metabolites in remyelination"   Brain. 2015 Feb;138(Pt 2):398-413  
16. Berrettini W. "Genetics of major mood disorders"   Psychiatry (Edgmont). 2004 Sep;1(2):38-48  
17. Cichon S. et al "Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorde"   Am J Hum Genet. 2011 Mar 11;88(3):372-81  
18. McClure D. et al "A Pilot Study of Safety and Efficacy of Cranial Electrotherapy Stimulation in Treatment of Bipolar II Depression"   J Nerv Ment Dis. 2015 Nov;203(11):827-35  
19. Patel DK. "An overview on antidiabetic medicinal plants having insulin mimetic property"   Asian Pac J Trop Biomed 2012 Apr;2(4):320-30  
20. Lawrie SM. et al "Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk"   Schizophr Bull. 2008 Mar;34(2):330-40  
21. Lu J. et al "Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models"   Neurosci Lett 2018 Nov 20;687:104-110  
22. Habauzit V. et al "Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians"   Ther Adv Chronic Dis. 2012 Mar;3(2):87-106  
23. Young IS. et al "Antioxidants in health and disease"   J Clin Pathol. 2001 Mar;54(3):176-86  
24. Yang N. et al "Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?"   Chin Med J (Engl). 2015 Sep 20;128(18):2530-4  
25. Nie L. "Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production"   Atherosclerosis 2006 Jun;186(2):260-6  
26. Witkowski M. et al "Gut Microbiota and Cardiovascular Disease"   Circ Res 2020 Jul 31;127(4):553-570  
27. Marković A. "Vasculitis and vasculopathy"   Acta Med Croatica. 2012 Oct;66 Suppl 1:19-24  
28. Scott AT. et al "Management of Small Bowel Neuroendocrine Tumors"   J Oncol Pract. 2018 Aug;14(8):471-482  
29. Taupin P. "Neurogenesis and Alzheimer's disease"   Drug Target Insights. 2006;1:1-4  
30. Modarresi F. et al "Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis"   Int J Alzheimers Dis. 2011;2011:929042  
31. Murphy MP. et al "Alzheimer's disease and the amyloid-beta peptide"   J Alzheimers Dis. 2010;19(1):311-23  
32. Lauretti E. et al "Effect of canola oil consumption on memory, synapse and neuropathology in the triple transgenic mouse model of Alzheimer's disease"   Sci Rep. 2017 Dec 7;7(1):17134  
33. Hurt JK. et al "Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine"   Plos one, 30 Oct 2012, 7(10):e48562  
34. Arellanes IC. et al "Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial"   EBioMedicine 2020 Jul 17;102883  
35. Liu L. et al "Herbal Medicine for Anxiety, Depression and Insomnia"   Curr Neuropharmacol. 2015;13(4):481-93  
36. Miller AL. "The Methylation, Neurotransmitter, and Antioxidant Connections Between Folate and Depression"   Altern Med Rev 2008 Sep;13(3):216-26  
37. Du X. et al "Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes"   Diabetologia. 2008 Oct;51(10):1930-2  
38. Frick PJ. et al "Current issues in the diagnosis of attention deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder"   Annu Rev Clin Psychol. 2012;8:77-107  
39. Rzepka-Migut B. et al "Efficacy and Safety of Melatonin Treatment in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder-A Review of the Literature"   Brain Sci 2020 Apr 7;10(4):219  
40. Julian LJ. "Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A)"   Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S467-72  
41. Benjamin J. et al "Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease"   World J Gastroenterol. 2008 Mar 7;14(9):1399-405  
42. Benjamin J. et al "Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial"   Dig Dis Sci. 2012 Apr;57(4):1000-12  
43. Smith JP. et al "Low-dose naltrexone therapy improves active Crohn's disease"   Am J Gastroenterol. 2007 Apr;102(4):820-8  
44. Gilberts EC. et al "Molecular evidence for two forms of Crohn disease"   Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12721-4  
45. Anderson CA. et al "Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47"   Nat Genet. 2011 Mar;43(3):246-52  
46. Hameed AM. "Significant elevations of serum lipase not caused by pancreatitis: a systematic review"   HPB (Oxford). 2015 Feb; 17(2): 99–112  
47. Kanne JP. et al "Eponyms in radiology of the digestive tract: historical perspectives and imaging appearances. Part 2. Liver, biliary system, pancreas, peritoneum, and systemic disease"   Radiographics Mar-Apr 2006;26(2):465-80  
48. Henke MT. "Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide"   Proc Natl Acad Sci U S A 2019 Jun 25;116(26):12672-12677  
49. Mannam P. et al "Oxidants in Acute and Chronic Lung Disease"   J Blood Lymph. 2014;4. pii: 1000128  
50. Mitchell K. et al "Effects of dietary nitrate on respiratory physiology at high altitude - Results from the Xtreme Alps study"   Nitric Oxide. 2017 Dec 1;71:57-68  
51. Snider GL. "Nosology for our day: its application to chronic obstructive pulmonary disease"   Am J Respir Crit Care Med. 2003 Mar 1;167(5):678-83  
52. Fu LW. et al "Systemic role for vitamin d in the treatment of psoriasis and metabolic syndrome"   Dermatol Res Pract. 2011;2011:276079  
53. Lobito AA. et al "Murine insulin growth factor-like (IGFL) and human IGFL1 proteins are induced in inflammatory skin conditions and bind to a novel tumor necrosis factor receptor family member, IGFLR1"   J Biol Chem. 2011 May 27;286(21):18969-81  
54. Jansen PA. et al "Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines"   J Invest Dermatol. 2009 Sep;129(9):2167-74  
55. Schmidt A. "Malassezia furfur: a fungus belonging to the physiological skin flora and its relevance in skin disorders"   Cutis. 1997 Jan;59(1):21-4  
56. Russell M. "Assessing the relationship between vitamin D3 and stratum corneum hydration for the treatment of xerotic skin"   Nutrients 2012 Sep;4(9):1213-8  
57. Takahashi Y. et al "Prophylactic and therapeutic effects of Acanthopanax senticosus Harms extract on murine collagen-induced arthritis"   Phytother Res. 2014 Oct;28(10):1513-9  
58. Cronstein BN. "Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis"   Pharmacol Rev. 2005 Jun;57(2):163-72  
59. Nazrun AS. et al "The anti-inflammatory role of vitamin e in prevention of osteoporosis"   Adv Pharmacol Sci 2012;2012:142702  
60. Kennedy PJ. et al "Irritable bowel syndrome: a microbiome-gut-brain axis disorder?"   World J Gastroenterol. 2014 Oct 21;20(39):14105-25  
61. Shiari R. "Neurologic manifestations of childhood rheumatic diseases"   Iran J Child Neurol. 2012 Fall;6(4):1-7  
62. Fan Y. et al "The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis"   Int J Immunogenet. 2011 Apr;38(2):151-9  
63. Reynolds JA. et al "Vitamin D treatment for connective tissue diseases: hope beyond the hype?"   Rheumatology (Oxford). 2017 Feb;56(2):178-186  
64. Hawn TR. et al "A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus"   Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10593-7  
65. Choi MK. et al "Relationship between dietary magnesium, manganese, and copper and metabolic syndrome risk in Korean adults: the Korea National Health and Nutrition Examination Survey (2007-2008)"   Biol Trace Elem Res. 2013 Dec;156(1-3):56-66  
66. Dalal JJ. et al "LIPITENSION: Interplay between dyslipidemia and hypertension"   Indian J Endocrinol Metab. 2012 Mar;16(2):240-5  
67. Tartaglia MC. et al "Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up"   Arch Neurol. 2007 Feb;64(2):232-6  
68. Mann RH. "Impaired Thiamine Metabolism in Amyotrophic Lateral Sclerosis and Its Potential Treatment With Benfotiamine: A Case Report and a Review of the Literature"   Cureus 2023 Jun 16;15(6):e40511  
69. Takeuchi T. et al "Four clinical types of panic disorders"   Jpn J Psychiatry Neurol 1992 Mar;46(1):37-44  
70. Demiralay C. "Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?"   Psychoneuroendocrinology 2017 Feb:76:14-18  
71. Bahmer T. et al "Physical Activity and Fatigue in Patients with Sarcoidosis"   Respiration. 2018;95(1):18-26  
72. Wenzel C. et al "Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients"   J Clin Psychopharmacol. 2012 Aug;32(4):548-50  
73. Lombroso PJ. et al "Tourette syndrome and obsessive-compulsive disorder"   Brain Dev. 2008 Apr;30(4):231-7  
74. Ito H. et al "Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report"   BMC Neurol. 2018 May 23;18(1):72  
 
    The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.